John McNulty's questions to Ecovyst Inc (ECVT) leadership • Q2 2025
Question
John McNulty of BMO Capital Markets asked for an update on the expected synergies from the Cornerstone (Wagaman) acquisition in 2026 and for more detail on the trial programs for emerging technologies like biocatalysis.
Answer
CFO Mike Feehan indicated that while 2025 will see integration costs offset sales, the Wagaman acquisition is expected to be a positive contributor in 2026 through synergies and new customer opportunities. CEO Kurt Bitting added that trial programs are focused on high-interest areas like using silicas for biocatalysis and catalysts for advanced recycling to improve energy efficiency.